Synthesis of ginger derived nanocarriers (GDNC) and study of in vitro release of 5-amino salicylic acid (5-ASA) as an anti inflammatory drug

被引:11
|
作者
Markam, Riya [1 ]
Bajpai, Jaya [1 ]
Bajpai, A. K. [1 ]
机构
[1] Govt Autonomous Sci Coll, Dept Chem, Bose Mem Res Lab, Jabalpur, MP, India
关键词
Inflammatory bowel disease; 5-Amino salicylic acid; Ginger nanocarriers; FTIR; TEM; BOWEL-DISEASE; DELIVERY; STABILITY; NANOPARTICLES; PREVENTION; EXTRACT;
D O I
10.1016/j.jddst.2019.01.039
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the present study ginger derived nanocarriers were prepared, characterized and used for the controlled release of an anti-inflammatory drug 5-ASA (5-amino salicylic acid). The mechanism of drug targeting was based on the release of 5-ASA drug molecules from the ginger derived nanocarriers having 62.24% drug loading capacity and 80.55% drug entrapment efficiency, and undergoing swelling in aqueous release medium. The present study considered the ginger not only for preparing nanocarriers but also as a medicine with anti-inflammatory, antioxidative and anti-bacterial actions. The nanocarriers obtained as a fine powder were characterized by different techniques such as Fourier-Transform Infrared Spectroscopy (FTIR), X-ray diffraction (XRD) analysis, Differential Scanning Calorimetry (DSC), Thermal Gravimetric Analysis (TGA), Scanning Electron Microscopy (SEM), Transmission Electron Microscopy (TEM), and Dynamic Light Scattering (DLS) based measurements of size and zeta potential, respectively. The particle size was found to be within 50 nm-100 nm range whereas the zeta potential was - 29.2 mV at pH 6.9. The effect of various factors like drug loading and entrapment efficiency, pH, and nature of the release medium was observed on the release profiles of 5-amino salicylic acid. The in vitro experiments were also conducted to check the stability of carriers in different pH environments and simulated biofluids.
引用
收藏
页码:355 / 364
页数:10
相关论文
共 50 条
  • [1] Functionalization of ginger derived nanoparticles with chitosan to design drug delivery system for controlled release of 5-amino salicylic acid (5-ASA) in treatment of inflammatory bowel diseases: An in vitro study
    Markam, Riya
    Bajpai, A. K.
    REACTIVE & FUNCTIONAL POLYMERS, 2020, 149
  • [2] 5-AMINO SALICYLIC-ACID (5-ASA) ENEMAS IN THE TREATMENT OF ACUTE ULCERATIVE-COLITIS - A CONTROLLED-STUDY
    PONTES, EL
    LEMME, EMO
    PORTO, JAF
    ZALTMAN, C
    DIGESTIVE DISEASES AND SCIENCES, 1986, 31 (10) : S381 - S381
  • [3] Anti-Inflammatory Activity of Chitosan and 5-Amino Salicylic Acid Combinations in Experimental Colitis
    Jhundoo, Henusha D.
    Siefen, Tobias
    Liang, Alfred
    Schmidt, Christoph
    Lokhnauth, John
    Beduneau, Arnaud
    Pellequer, Yann
    Larsen, Crilles Casper
    Lamprecht, Alf
    PHARMACEUTICS, 2020, 12 (11) : 1 - 16
  • [4] 5-AMINO-SALICYLIC ACID (5-ASA) ENEMAS ARE EFFECTIVE IN PATIENTS WITH RESISTENT ULCERATIVE RECTOSIGMOIDITIS
    JANSSENS, J
    GEBOES, K
    DELANOTE, C
    VANTRAPPEN, G
    GASTROENTEROLOGY, 1983, 84 (05) : 1198 - 1198
  • [5] 5-amino-salicylic acid (5-ASA)-induced nephrotoxicity is dose dependent in rats.
    Lundberg, C
    Asberg, I
    Smedegard, G
    Berglindh, T
    GASTROENTEROLOGY, 1996, 110 (04) : A952 - A952
  • [6] Controlled drug release of 5-amino salicylic acid by poly(2-hydroxyethylmethacrylate) grafted agar
    G.Usha RANI
    Kartick Prasad DEY
    Srijita BHARTI
    Sumit MISHRA
    Frontiers of Chemical Science and Engineering, 2014, 8 (04) : 465 - 470
  • [7] SYNTHESIS OF 5-AMINO[CARBOXYL-C-14]SALICYLIC ACID
    JORGENSEN, O
    PETERSEN, S
    CARLSEN, L
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1987, 24 (11): : 1393 - 1395
  • [8] Controlled drug release of 5-amino salicylic acid by poly(2-hydroxyethylmethacrylate) grafted agar
    Rani, G. Usha
    Dey, Kartick Prasad
    Bharti, Srijita
    Mishra, Sumit
    FRONTIERS OF CHEMICAL SCIENCE AND ENGINEERING, 2014, 8 (04) : 465 - 470
  • [9] Controlled drug release of 5-amino salicylic acid by poly(2-hydroxyethylmethacrylate) grafted agar
    G. Usha Rani
    Kartick Prasad Dey
    Srijita Bharti
    Sumit Mishra
    Frontiers of Chemical Science and Engineering, 2014, 8 : 465 - 470
  • [10] 5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease
    Pertuit, David
    Moulari, Brice
    Betz, Thomas
    Nadaradjane, Amlraj
    Neumann, Dirk
    Ismaili, Lhassane
    Refouvelet, Bernard
    Pellequer, Yann
    Lamprecht, Alf
    JOURNAL OF CONTROLLED RELEASE, 2007, 123 (03) : 211 - 218